Results per Page:
Two doses of the HPV vaccine is all you need
Long-term immunity from human papillomavirus infections — and the deadly cancers they can drive — reached with just two jabs
Starting the year smarter
How patients, providers, researchers and others stay informed amid a deluge of data and information
After a rare nasopharynx carcinoma diagnosis, North Carolina resident looked to experts at Fred Hutch
Proton therapy was an integral part of Mark James’ treatment
Fred Hutch announces eight recipients of 2024 Dr. Eddie Méndez Scholar Award
National award recognizes exceptional postdoctoral researchers from historically underrepresented groups in science
The Beam: Protons for head and neck cancers, a look at our RTTs, meet Angelle Schilling
When are protons indicated for head and neck cancers? A deeper look at the role of radiation therapists and an introduction to our newest nurse
First neurosurgery, then head and neck cancer
'World-class care' and leading-edge science help Seattle patient overcome dual diagnoses
Solid tumors use a type of T cell as a shield against immune attack
Discovery in head and neck cancers may open door for targeted immune-boosting drugs
WEE1i treatment acts on profound cell cycle dysregulation in HPV-positive head and neck squamous cell carcinoma
From the Clurman lab, Human Biology and Clinical Research Divisions
Single dad takes on head and neck cancer at the SCCA proton therapy center
The unicyclist's diagnosis at 39 came as a shock.
Dr. Zhe Ying receives award to study how head and neck cancers overcome newly discovered tumor-blocking mechanism
Postdoc’s Pathway to Independence Award will help lay the foundation for his early career
Two Irish microbiologists find their way, together, to Seattle
Microbiome experts Drs. Susan Bullman and Christopher Johnston join Fred Hutch
How to talk to parents about HPV vaccines
Fred Hutch public health researcher shares science-based tips to help doctors navigate crucial cancer-prevention conversations